Phillips-Medisize Archives - Medical Design Sourcing

Molex opens new Phillips-Medisize manufacturing facility

Molex — owned by Koch Industries — already has plans to expand its new Phillips-Medisize facility in Katowice, Poland.[Image courtesy of Molex]

Molex today announced the opening of a new campus in Katowice, Poland, for Phillips-Medisize, its medical device contract development and manufacturing organization subsidiary.

The facility has 23,000 m² of manufacturing space, and Molex plans to later expand the facility to as much as 85,000 m².

Molex — owned by Wichita, Kansas-based Koch Industries — said it has invested $110 million in the campus. It will initially support Phillips-Medisize with production of pharmaceutical, medical and diagnostic devices.

The first facilities on the campus will have around 350 employees at planned capacity, including highly skilled production operators, design engineers and quality specialists, Molex said..

“The Katowice campus will expand our European foo…

Phillips-Medisize, GlucoModicum partner on needle-free CGM

The Talisman CGM for non-invasive diabetes management. [Image courtesy of GlucoModicum/Phillips-Medisize]Molex company Phillips-Medisize today announced a partnership with GlucoModicum to design a new continuous glucose monitor (CGM).

The companies teamed up to design and eventually commercialize a proprietary, non-invasive, wearable CGM device. They aim to remove the technology and patient-care roadblocks that exist within continuous glucose monitoring.

Phillips-Medisize develops drug delivery, in vitro diagnostic and medtech devices. Finland-based GlucoModicum utilizes magnetohydrodynamic (MHD) technology to quickly and easily extract a glucose sample. This technology applies a small amount of energy directly to interstitial fluid to drive it to the surface of the skin.

The device utilizing this technology, called Talisman, adheres to a patient’s arm. It integrates MHD technology, ultra-sensitive biosensors and advanced algorithms while connecting t…

Phillips-Medisize and Modular Medical partner on insulin delivery alternatives

Phillips-Medisize designed and developed manufacturing and assembly for Modular’s MODD1 insulin delivery system. [Image courtesy of Modular Medical]

NEWS RELEASE: Modular Medical Partners with Phillips-Medisize to Expand Insulin Delivery Alternatives Modular Medical, Inc. (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced a collaboration under which Phillips-Medisize, a Molex company and a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, invitro diagnostic, medtech and specialty consumer devices, is providing Modular Medical with design, development and high-volume manufacturing capabilities.

Phillips-Medisize leveraged its global, diversified supplier base and deep medical device and diabetes disease experience to desi…

Phillips-Medisize unveils new disposable injector pen

[Image courtesy of Phillips-Medisize]

Phillips-Medisize, a Molex company, announced today that it expanded its product portfolio with a new disposable pen injector.

Hudson, Wisconsin-based Phillips-Medisize designed the new injector for high-volume manufacturing. It intends to offer pharmaceutical companies a familiar, competitive pen injector for faster, more efficient and cost-effective market entry.

Get the full story at our sister site, Drug Delivery Business News.

Phillips-Medisize unveils new disposable injector pen

The newly unveiled disposable pen injector. [Image courtesy of Phillips-Medisize]Phillips-Medisize, a Molex company, announced today that it expanded its product portfolio with a new disposable pen injector.

Hudson, Wisconsin-based Phillips-Medisize designed the new injector for high-volume manufacturing. It intends to offer pharmaceutical companies a familiar, competitive pen injector for faster, more efficient and cost-effective market entry.

The company plans to display the pen at Pharmapack Europe, according to a news release.

“A pen injector is an important addition to Phillips-Medisize’s expanding product and platform portfolio that empowers biopharma companies to accelerate the rollout of novel and generic drug treatments at significant economies of scale,” said Paul Chaffin, SVP and president of medical and pharmaceutical solutions, Molex. “This ‘ready to go’ solution offers all of the advantages expected from ‘state of the art’ pen designs while be…

6 drug delivery innovations you need to know

From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops.

Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies.

More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With some updates on some of those technologies, plus introductions to others, here are some more impressive developments you should keep an eye on:

1. Needle-free delivery

Vaccines have become a major talking point over the past couple of years amid the COVID-19 pandemic and a number of companies are working on ways to deliver them, as well as other forms of medication, through different avenues.

A major speed bump in vaccine hesitancy can be fear of needles, so the introduction of needle-free drug delivery could make big waves in the space.

Two companies pushing forward with …

How Phillips-Medisize helped Sotech Health develop a breath analyzer for COVID-19

Sotech Health and Phillips-Medisize claim the breath analyzer can detect traces of the virus that causes COVID-19 within 30 seconds. [Image courtesy of Phillips-Medisize and Sotech Health]Medtech contract manufacturing giant Phillips-Medisize used its human-factors product design expertise to help startup Sotech Health create what the companies claim is a breath sensor system that can detect COVID-19 in less than 30 seconds.

Dallas-based Sotech Health has submitted the device to the FDA for an emergency use authorization. It’s also seeking regulatory nods in Canada, the United Kingdom and the European Union.

Phillips-Medisize (Hudson, Wisconsin) is readying its global production facilities to keep pace with the anticipated demand for the Sotech Health breath analyzer. A Molex company, Phillips-Medisize has 36 facilities worldwide.

Get the full story on our sister site Medical Design & Outsourcing.

How Phillips-Medisize helped Sotech Health develop a breath analyzer for COVID-19

Sotech Health and Phillips-Medisize claim the breath analyzer can detect traces of the virus that causes COVID-19 within 30 seconds. [Image courtesy of Phillips-Medisize and Sotech Health]

Medtech contract manufacturing giant Phillips-Medisize used its human-factors product design expertise to help startup Sotech Health create what the companies claim is a breath sensor system that can detect COVID-19 in less than 30 seconds.

Dallas-based Sotech Health has submitted the device to the FDA for an emergency use authorization. It’s also seeking regulatory nods in Canada, the United Kingdom and the European Union.

Phillips-Medisize (Hudson, Wisconsin) is readying its global production facilities to keep pace with the anticipated demand for the Sotech Health breath analyzer. A Molex company, Phillips-Medisize has 36 facilities worldwide.

The contract manufacturer boasts that its electronics, produ…

Phillips-Medisize, Exact Sciences to collaborate on colorectal cancer screening

Phillips-Medisize and Exact Sciences (NSDQ:EXAS) today announced a collaboration to advance early cancer detection.

The collaboration centers around Exact Sciences’ Cologuard, the first and only FDA-approved, non-invasive stool DNA screening test for colorectal cancer, according to a news release.

Phillips-Medisize, a Molex company, said the collaboration will seek to focus on the patient experience through the simplicity and convenience of at-home testing. The company developed new tooling to safeguard against inadvertent leaks while meeting specifications and tolerances required to produce the highest levels of product quality.

Exact Sciences was able to utilize supply chain flexibility to acquire all components needed to rapidly scale production of the kit, while Phillips-Medisize located and validated alternate supply sources, conducted risk assessments and forecasting and created sourcing and procurement plans to protect against unplanned disr…

Phillips-Medisize expands its global manufacturing capacity

Phillips-Medisize announced today that it expanded its global manufacturing capacity through a number of collaborations and internal initiatives.

Hudson, Wisconsin-based Phillips-Medisize, a Molex company, said its global reach now encompasses 36 world-class facilities with scalable, end-to-end capabilities tailored to help customers bring products to market quickly and efficiently from anywhere in the world.

Get the full story at our sister site, Medical Design & Outsourcing.

Phillips-Medisize expands its global manufacturing capacity

Phillips-Medisize announced today that it expanded its global manufacturing capacity through a number of collaborations and internal initiatives.

Hudson, Wisconsin-based Phillips-Medisize, a Molex company, said its global reach now encompasses 36 world-class facilities with scalable, end-to-end capabilities tailored to help customers bring products to market quickly and efficiently from anywhere in the world.

“As the preferred partner for leading global customers, we continually invest in new talent and technologies that increase the capacity and capabilities of Phillips-Medisize across the entire value chain,” Molex president of medical & pharmaceutical solutions Paul Chaffin said in a news release. “Our expanded global reach and resources will enable us to solve complex development and manufacturing challenges while meeting escalating customer demands for more localized production, supply chain management and accelerated go-to-market strategies.”

P…

Phillips-Medisize unveils Aria smart autoinjector

Phillips-Medisize Aria Smart Autoinjector platform featuring a reusable electronic drive unit and single-use, disposable cassettes [Image from Phillips-Medisize]

Phillips-Medisize today unveiled the Aria smart autoinjector platform designed to elevate patient care and reduce environmental impact.

Hudson, Wis.-based Phillips-Medisize, a Molex company, said in a news release that the Aria platform introduces a small, simple smart injection device with a reusable electronic drive unit and single-use, disposable cassettes.

Get the full story at our sister site, Drug Delivery Business News.